Phage Pharmaceuticals, Inc.

Phage Pharmaceuticals is a private biopharmaceutical company based in San Diego, CA, USA. Phage is a product focused platform company with technology developed around a proprietary E. coli bacterial protein expression system. The technology results in the production of properly folded therapeutic proteins which remain soluble with high supernatant concentrations. Our product focus targets key therapeutics areas including: cardiovascular disease, wound care, cosmetics, vaccines, and auditory disease. Phage has a current portfolio of biosimilar protein therapeutics. Contract R+D services for the development of difficult insoluble proteins using our Intelligent Protein expression system are available.

网站

http://www.phagepharma.com

Phage Pharmaceuticals, Inc.的外部链接

所属行业

生物技术研究

规模

11-50 人

总部

San Diego，CA

类型

私人持股

领域

"Intelligent Protein" E.coli-based expression system、Recombinant proteins、Biosimilars、Wound Healing、Tympanic Membrane Perforation、Cardiovascular、Cosmetics、Contract Manufacturing、Expression optimization for hard-to-express proteins、Biobetters和Vaccines